# Global Payments

Type: Company (GPN)

Source: GetYourBrief — https://getyourbrief.com/entity/global-payments
Canonical HTML page: https://getyourbrief.com/entity/global-payments

## Recent coverage (5 stories, network-wide)

### Stripe’s $53.4B PayPal Bid Could Reshape SaaS Payments Infrastructure
2026-07-15 15:40:46 · Sector: saas · Sentiment: Positive · Impact: 9/10 · Sources: 5

The joint $53.4 billion bid by Stripe and Advent to acquire PayPal would create a payments behemoth processing over $3.7 trillion annually, directly impacting the SaaS ecosystem. For cloud businesses relying on Stripe’s APIs or PayPal’s checkout, a merger could unify fragmented payment rails, introduce new cross-sell opportunities, and alter competitive dynamics among payment processors.
Full story: https://getsaasbrief.com/story/stripe-paypal-acquisition-saas-payments

### Invenomic Capital Management Exits Haemonetics After Year of Underperformance
2026-03-21 01:09:40 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Invenomic Capital Management has fully liquidated its $24.3 million stake in Haemonetics Corporation (HAE) following a period of significant market underperformance. The move signals a strategic shift for the fund as it reallocates capital toward more resilient healthcare and technology holdings.
Full story: https://getfinancebrief.com/story/invenomic-capital-haemonetics-exit-analysis

### Invenomic Capital Exits $24M Haemonetics Stake Amid MedTech Underperformance
2026-03-21 01:09:37 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, signaling a shift away from the underperforming medical device maker. The exit comes as Haemonetics shares have lagged the broader market, dropping 9% over the past year while the fund rotates capital into diversified healthcare and technology plays.
Full story: https://getbiobrief.com/story/invenomic-capital-exits-haemonetics-stake-medtech-underperformance

### Invenomic Capital Exits $24M Haemonetics Stake Amid Med-Tech Underperformance
2026-03-21 01:09:03 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, a leader in blood and plasma management technology. The exit comes as the stock underperformed the broader market by 25% over the past year, signaling a shift in institutional sentiment toward the medical device sector.
Full story: https://gethealthbrief.com/story/invenomic-capital-exits-haemonetics-stake

### Global-E and Global Payments Set for Q4 2025 Earnings Amid E-commerce Shift
2026-02-17 18:05:48 · Sector: saas · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Global-E Online and Global Payments are preparing to report Q4 2025 results, offering a critical look at cross-border e-commerce momentum and the success of software-led payment strategies. These reports will serve as a barometer for global consumer spending resilience at the close of the fiscal year.
Full story: https://getsaasbrief.com/story/global-e-global-payments-q4-2025-earnings-preview

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.